<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1997-11-01" modified="2020-04-22" version="215">
<accession>Q13546</accession>
<accession>A0AV89</accession>
<accession>B2RAG1</accession>
<accession>B4E3F9</accession>
<accession>Q13180</accession>
<accession>Q59H33</accession>
<name>RIPK1_HUMAN</name>
<protein>
<recommendedName>
<fullName>Receptor-interacting serine/threonine-protein kinase 1</fullName>
<ecNumber evidence="45 52">2.7.11.1</ecNumber>
</recommendedName>
<alternativeName>
<fullName>Cell death protein RIP</fullName>
</alternativeName>
<alternativeName>
<fullName>Receptor-interacting protein 1</fullName>
<shortName>RIP-1</shortName>
</alternativeName>
</protein>
<gene>
<name type="primary">RIPK1</name>
<name type="synonym">RIP</name>
<name type="synonym">RIP1</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1996" name="Immunity" volume="4" first="387" last="396">
<title>TNF-dependent recruitment of the protein kinase RIP to the TNF receptor-1 signaling complex.</title>
<authorList>
<person name="Hsu H."/>
<person name="Huang J."/>
<person name="Shu H.-B."/>
<person name="Baichwal V.R."/>
<person name="Goeddel D.V."/>
</authorList>
<dbReference type="PubMed" id="8612133"/>
<dbReference type="DOI" id="10.1016/s1074-7613(00)80252-6"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>AUTOPHOSPHORYLATION</scope>
<scope>MUTAGENESIS OF LYS-45</scope>
<scope>INTERACTION WITH TRADD; TRAF1; TRAF2 AND TRAF3</scope>
<scope>VARIANT VAL-438</scope>
<source>
<tissue>Umbilical vein endothelial cell</tissue>
</source>
</reference>
<reference key="2">
<citation type="submission" date="1998-08" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Huang J."/>
<person name="Hsu H."/>
<person name="Baichwal V.R."/>
<person name="Goeddel D.V."/>
</authorList>
</citation>
<scope>SEQUENCE REVISION TO 120</scope>
</reference>
<reference key="3">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 15-671 (ISOFORM 2)</scope>
<source>
<tissue>Adrenal gland</tissue>
<tissue>Uterus</tissue>
</source>
</reference>
<reference key="4">
<citation type="submission" date="2004-07" db="EMBL/GenBank/DDBJ databases">
<authorList>
<consortium name="SeattleSNPs variation discovery resource"/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>VARIANT LYS-234</scope>
</reference>
<reference key="5">
<citation type="journal article" date="2003" name="Nature" volume="425" first="805" last="811">
<title>The DNA sequence and analysis of human chromosome 6.</title>
<authorList>
<person name="Mungall A.J."/>
<person name="Palmer S.A."/>
<person name="Sims S.K."/>
<person name="Edwards C.A."/>
<person name="Ashurst J.L."/>
<person name="Wilming L."/>
<person name="Jones M.C."/>
<person name="Horton R."/>
<person name="Hunt S.E."/>
<person name="Scott C.E."/>
<person name="Gilbert J.G.R."/>
<person name="Clamp M.E."/>
<person name="Bethel G."/>
<person name="Milne S."/>
<person name="Ainscough R."/>
<person name="Almeida J.P."/>
<person name="Ambrose K.D."/>
<person name="Andrews T.D."/>
<person name="Ashwell R.I.S."/>
<person name="Babbage A.K."/>
<person name="Bagguley C.L."/>
<person name="Bailey J."/>
<person name="Banerjee R."/>
<person name="Barker D.J."/>
<person name="Barlow K.F."/>
<person name="Bates K."/>
<person name="Beare D.M."/>
<person name="Beasley H."/>
<person name="Beasley O."/>
<person name="Bird C.P."/>
<person name="Blakey S.E."/>
<person name="Bray-Allen S."/>
<person name="Brook J."/>
<person name="Brown A.J."/>
<person name="Brown J.Y."/>
<person name="Burford D.C."/>
<person name="Burrill W."/>
<person name="Burton J."/>
<person name="Carder C."/>
<person name="Carter N.P."/>
<person name="Chapman J.C."/>
<person name="Clark S.Y."/>
<person name="Clark G."/>
<person name="Clee C.M."/>
<person name="Clegg S."/>
<person name="Cobley V."/>
<person name="Collier R.E."/>
<person name="Collins J.E."/>
<person name="Colman L.K."/>
<person name="Corby N.R."/>
<person name="Coville G.J."/>
<person name="Culley K.M."/>
<person name="Dhami P."/>
<person name="Davies J."/>
<person name="Dunn M."/>
<person name="Earthrowl M.E."/>
<person name="Ellington A.E."/>
<person name="Evans K.A."/>
<person name="Faulkner L."/>
<person name="Francis M.D."/>
<person name="Frankish A."/>
<person name="Frankland J."/>
<person name="French L."/>
<person name="Garner P."/>
<person name="Garnett J."/>
<person name="Ghori M.J."/>
<person name="Gilby L.M."/>
<person name="Gillson C.J."/>
<person name="Glithero R.J."/>
<person name="Grafham D.V."/>
<person name="Grant M."/>
<person name="Gribble S."/>
<person name="Griffiths C."/>
<person name="Griffiths M.N.D."/>
<person name="Hall R."/>
<person name="Halls K.S."/>
<person name="Hammond S."/>
<person name="Harley J.L."/>
<person name="Hart E.A."/>
<person name="Heath P.D."/>
<person name="Heathcott R."/>
<person name="Holmes S.J."/>
<person name="Howden P.J."/>
<person name="Howe K.L."/>
<person name="Howell G.R."/>
<person name="Huckle E."/>
<person name="Humphray S.J."/>
<person name="Humphries M.D."/>
<person name="Hunt A.R."/>
<person name="Johnson C.M."/>
<person name="Joy A.A."/>
<person name="Kay M."/>
<person name="Keenan S.J."/>
<person name="Kimberley A.M."/>
<person name="King A."/>
<person name="Laird G.K."/>
<person name="Langford C."/>
<person name="Lawlor S."/>
<person name="Leongamornlert D.A."/>
<person name="Leversha M."/>
<person name="Lloyd C.R."/>
<person name="Lloyd D.M."/>
<person name="Loveland J.E."/>
<person name="Lovell J."/>
<person name="Martin S."/>
<person name="Mashreghi-Mohammadi M."/>
<person name="Maslen G.L."/>
<person name="Matthews L."/>
<person name="McCann O.T."/>
<person name="McLaren S.J."/>
<person name="McLay K."/>
<person name="McMurray A."/>
<person name="Moore M.J.F."/>
<person name="Mullikin J.C."/>
<person name="Niblett D."/>
<person name="Nickerson T."/>
<person name="Novik K.L."/>
<person name="Oliver K."/>
<person name="Overton-Larty E.K."/>
<person name="Parker A."/>
<person name="Patel R."/>
<person name="Pearce A.V."/>
<person name="Peck A.I."/>
<person name="Phillimore B.J.C.T."/>
<person name="Phillips S."/>
<person name="Plumb R.W."/>
<person name="Porter K.M."/>
<person name="Ramsey Y."/>
<person name="Ranby S.A."/>
<person name="Rice C.M."/>
<person name="Ross M.T."/>
<person name="Searle S.M."/>
<person name="Sehra H.K."/>
<person name="Sheridan E."/>
<person name="Skuce C.D."/>
<person name="Smith S."/>
<person name="Smith M."/>
<person name="Spraggon L."/>
<person name="Squares S.L."/>
<person name="Steward C.A."/>
<person name="Sycamore N."/>
<person name="Tamlyn-Hall G."/>
<person name="Tester J."/>
<person name="Theaker A.J."/>
<person name="Thomas D.W."/>
<person name="Thorpe A."/>
<person name="Tracey A."/>
<person name="Tromans A."/>
<person name="Tubby B."/>
<person name="Wall M."/>
<person name="Wallis J.M."/>
<person name="West A.P."/>
<person name="White S.S."/>
<person name="Whitehead S.L."/>
<person name="Whittaker H."/>
<person name="Wild A."/>
<person name="Willey D.J."/>
<person name="Wilmer T.E."/>
<person name="Wood J.M."/>
<person name="Wray P.W."/>
<person name="Wyatt J.C."/>
<person name="Young L."/>
<person name="Younger R.M."/>
<person name="Bentley D.R."/>
<person name="Coulson A."/>
<person name="Durbin R.M."/>
<person name="Hubbard T."/>
<person name="Sulston J.E."/>
<person name="Dunham I."/>
<person name="Rogers J."/>
<person name="Beck S."/>
</authorList>
<dbReference type="PubMed" id="14574404"/>
<dbReference type="DOI" id="10.1038/nature02055"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
<scope>VARIANT VAL-438</scope>
</reference>
<reference key="7">
<citation type="submission" date="2005-03" db="EMBL/GenBank/DDBJ databases">
<title>Homo sapiens protein coding cDNA.</title>
<authorList>
<person name="Totoki Y."/>
<person name="Toyoda A."/>
<person name="Takeda T."/>
<person name="Sakaki Y."/>
<person name="Tanaka A."/>
<person name="Yokoyama S."/>
<person name="Ohara O."/>
<person name="Nagase T."/>
<person name="Kikuno R.F."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 153-671</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="8">
<citation type="journal article" date="1995" name="Cell" volume="81" first="513" last="523">
<title>RIP: a novel protein containing a death domain that interacts with Fas/APO-1 (CD95) in yeast and causes cell death.</title>
<authorList>
<person name="Stanger B.Z."/>
<person name="Leder P."/>
<person name="Lee T.-H."/>
<person name="Kim E."/>
<person name="Seed B."/>
</authorList>
<dbReference type="PubMed" id="7538908"/>
<dbReference type="DOI" id="10.1016/0092-8674(95)90072-1"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 300-671</scope>
<scope>VARIANT VAL-438</scope>
<source>
<tissue>Leukemic T-cell</tissue>
</source>
</reference>
<reference key="9">
<citation type="journal article" date="1997" name="Cancer Res." volume="57" first="615" last="619">
<title>CRADD, a novel human apoptotic adaptor molecule for caspase-2, and FasL/tumor necrosis factor receptor-interacting protein RIP.</title>
<authorList>
<person name="Ahmad M."/>
<person name="Srinivasula S.M."/>
<person name="Wang L."/>
<person name="Talanian R.V."/>
<person name="Litwack G."/>
<person name="Fernandes-Alnemri T."/>
<person name="Alnemri E.S."/>
</authorList>
<dbReference type="PubMed" id="9044836"/>
</citation>
<scope>INTERACTION WITH CRADD</scope>
<scope>DOMAIN</scope>
</reference>
<reference key="10">
<citation type="journal article" date="1999" name="Genes Dev." volume="13" first="2514" last="2526">
<title>Cleavage of the death domain kinase RIP by caspase-8 prompts TNF-induced apoptosis.</title>
<authorList>
<person name="Lin Y."/>
<person name="Devin A."/>
<person name="Rodriguez Y."/>
<person name="Liu Z.-G."/>
</authorList>
<dbReference type="PubMed" id="10521396"/>
<dbReference type="DOI" id="10.1101/gad.13.19.2514"/>
</citation>
<scope>CLEAVAGE BY CASP8</scope>
<scope>MUTAGENESIS OF ASP-324</scope>
</reference>
<reference key="11">
<citation type="journal article" date="1999" name="EMBO J." volume="18" first="3044" last="3053">
<title>The interaction of p62 with RIP links the atypical PKCs to NF-kappaB activation.</title>
<authorList>
<person name="Sanz L."/>
<person name="Sanchez P."/>
<person name="Lallena M.-J."/>
<person name="Diaz-Meco M.T."/>
<person name="Moscat J."/>
</authorList>
<dbReference type="PubMed" id="10356400"/>
<dbReference type="DOI" id="10.1093/emboj/18.11.3044"/>
</citation>
<scope>INTERACTION WITH SQSTM1 AND TRAF2</scope>
<scope>DOMAIN DEATH</scope>
</reference>
<reference key="12">
<citation type="journal article" date="1999" name="J. Biol. Chem." volume="274" first="16871" last="16875">
<title>RIP3, a novel apoptosis-inducing kinase.</title>
<authorList>
<person name="Sun X."/>
<person name="Lee J."/>
<person name="Navas T."/>
<person name="Baldwin D.T."/>
<person name="Stewart T.A."/>
<person name="Dixit V.M."/>
</authorList>
<dbReference type="PubMed" id="10358032"/>
<dbReference type="DOI" id="10.1074/jbc.274.24.16871"/>
</citation>
<scope>INTERACTION WITH RIPK3</scope>
</reference>
<reference key="13">
<citation type="journal article" date="1999" name="Mol. Cell. Biol." volume="19" first="5759" last="5767">
<title>The Epstein-Barr virus oncoprotein latent membrane protein 1 engages the tumor necrosis factor receptor-associated proteins TRADD and receptor-interacting protein (RIP) but does not induce apoptosis or require RIP for NF-kappaB activation.</title>
<authorList>
<person name="Izumi K.M."/>
<person name="Cahir McFarland E."/>
<person name="Ting A.T."/>
<person name="Riley E.A."/>
<person name="Seed B."/>
<person name="Kieff E.D."/>
</authorList>
<dbReference type="PubMed" id="10409763"/>
<dbReference type="DOI" id="10.1128/mcb.19.8.5759"/>
</citation>
<scope>INTERACTION WITH BNLF1</scope>
</reference>
<reference key="14">
<citation type="journal article" date="1999" name="Proc. Natl. Acad. Sci. U.S.A." volume="96" first="1042" last="1047">
<title>Identification of a cell protein (FIP-3) as a modulator of NF-kappaB activity and as a target of an adenovirus inhibitor of tumor necrosis factor alpha-induced apoptosis.</title>
<authorList>
<person name="Li Y."/>
<person name="Kang J."/>
<person name="Friedman J."/>
<person name="Tarassishin L."/>
<person name="Ye J."/>
<person name="Kovalenko A."/>
<person name="Wallach D."/>
<person name="Horwitz M.S."/>
</authorList>
<dbReference type="PubMed" id="9927690"/>
<dbReference type="DOI" id="10.1073/pnas.96.3.1042"/>
</citation>
<scope>INTERACTION WITH IKBKG</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2000" name="Nat. Immunol." volume="1" first="489" last="495">
<title>Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule.</title>
<authorList>
<person name="Holler N."/>
<person name="Zaru R."/>
<person name="Micheau O."/>
<person name="Thome M."/>
<person name="Attinger A."/>
<person name="Valitutti S."/>
<person name="Bodmer J.L."/>
<person name="Schneider P."/>
<person name="Seed B."/>
<person name="Tschopp J."/>
</authorList>
<dbReference type="PubMed" id="11101870"/>
<dbReference type="DOI" id="10.1038/82732"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2001" name="J. Biol. Chem." volume="276" first="8865" last="8874">
<title>The epidermal growth factor receptor engages receptor interacting protein and nuclear factor-kappa B (NF-kappa B)-inducing kinase to activate NF-kappa B. Identification of a novel receptor-tyrosine kinase signalosome.</title>
<authorList>
<person name="Habib A.A."/>
<person name="Chatterjee S."/>
<person name="Park S.-K."/>
<person name="Ratan R.R."/>
<person name="Lefebvre S."/>
<person name="Vartanian T."/>
</authorList>
<dbReference type="PubMed" id="11116146"/>
<dbReference type="DOI" id="10.1074/jbc.m008458200"/>
</citation>
<scope>INTERACTION WITH EGFR</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2002" name="J. Biol. Chem." volume="277" first="15985" last="15991">
<title>A novel zinc finger protein interacts with receptor-interacting protein (RIP) and inhibits tumor necrosis factor (TNF)- and IL1-induced NF-kappa B activation.</title>
<authorList>
<person name="Chen D."/>
<person name="Li X."/>
<person name="Zhai Z."/>
<person name="Shu H.-B."/>
</authorList>
<dbReference type="PubMed" id="11854271"/>
<dbReference type="DOI" id="10.1074/jbc.m108675200"/>
</citation>
<scope>INTERACTION WITH RNF216</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2002" name="J. Biol. Chem." volume="277" first="9505" last="9511">
<title>Identification of a novel homotypic interaction motif required for the phosphorylation of receptor-interacting protein (RIP) by RIP3.</title>
<authorList>
<person name="Sun X."/>
<person name="Yin J."/>
<person name="Starovasnik M.A."/>
<person name="Fairbrother W.J."/>
<person name="Dixit V.M."/>
</authorList>
<dbReference type="PubMed" id="11734559"/>
<dbReference type="DOI" id="10.1074/jbc.m109488200"/>
</citation>
<scope>RIP HOMOTYPIC INTERACTION MOTIF</scope>
<scope>INTERACTION WITH RIPK3</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2004" name="Anal. Chem." volume="76" first="2763" last="2772">
<title>Robust phosphoproteomic profiling of tyrosine phosphorylation sites from human T cells using immobilized metal affinity chromatography and tandem mass spectrometry.</title>
<authorList>
<person name="Brill L.M."/>
<person name="Salomon A.R."/>
<person name="Ficarro S.B."/>
<person name="Mukherji M."/>
<person name="Stettler-Gill M."/>
<person name="Peters E.C."/>
</authorList>
<dbReference type="PubMed" id="15144186"/>
<dbReference type="DOI" id="10.1021/ac035352d"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-384</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Leukemic T-cell</tissue>
</source>
</reference>
<reference key="20">
<citation type="journal article" date="2004" name="J. Biol. Chem." volume="279" first="16847" last="16853">
<title>ZNF216 is an A20-like and IkappaB kinase gamma-interacting inhibitor of NFkappaB activation.</title>
<authorList>
<person name="Huang J."/>
<person name="Teng L."/>
<person name="Li L."/>
<person name="Liu T."/>
<person name="Li L."/>
<person name="Chen D."/>
<person name="Xu L.-G."/>
<person name="Zhai Z."/>
<person name="Shu H.-B."/>
</authorList>
<dbReference type="PubMed" id="14754897"/>
<dbReference type="DOI" id="10.1074/jbc.m309491200"/>
</citation>
<scope>INTERACTION WITH ZFAND5</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2004" name="Nature" volume="430" first="694" last="699">
<title>De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling.</title>
<authorList>
<person name="Wertz I.E."/>
<person name="O'Rourke K.M."/>
<person name="Zhou H."/>
<person name="Eby M."/>
<person name="Aravind L."/>
<person name="Seshagiri S."/>
<person name="Wu P."/>
<person name="Wiesmann C."/>
<person name="Baker R."/>
<person name="Boone D.L."/>
<person name="Ma A."/>
<person name="Koonin E.V."/>
<person name="Dixit V.M."/>
</authorList>
<dbReference type="PubMed" id="15258597"/>
<dbReference type="DOI" id="10.1038/nature02794"/>
</citation>
<scope>UBIQUITINATION BY TRAF2</scope>
<scope>DEUBIQUITINATION BY TNFAIP3</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2005" name="Nat. Immunol." volume="6" first="981" last="988">
<title>IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction.</title>
<authorList>
<person name="Kawai T."/>
<person name="Takahashi K."/>
<person name="Sato S."/>
<person name="Coban C."/>
<person name="Kumar H."/>
<person name="Kato H."/>
<person name="Ishii K.J."/>
<person name="Takeuchi O."/>
<person name="Akira S."/>
</authorList>
<dbReference type="PubMed" id="16127453"/>
<dbReference type="DOI" id="10.1038/ni1243"/>
</citation>
<scope>INTERACTION WITH MAVS</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2006" name="Mol. Cell" volume="22" first="245" last="257">
<title>Activation of IKK by TNFalpha requires site-specific ubiquitination of RIP1 and polyubiquitin binding by NEMO.</title>
<authorList>
<person name="Ea C.K."/>
<person name="Deng L."/>
<person name="Xia Z.P."/>
<person name="Pineda G."/>
<person name="Chen Z.J."/>
</authorList>
<dbReference type="PubMed" id="16603398"/>
<dbReference type="DOI" id="10.1016/j.molcel.2006.03.026"/>
</citation>
<scope>UBIQUITINATION AT LYS-377</scope>
<scope>MUTAGENESIS OF LYS-377</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2007" name="Cell Death Differ." volume="14" first="400" last="410">
<title>RIP1, a kinase on the crossroads of a cell's decision to live or die.</title>
<authorList>
<person name="Festjens N."/>
<person name="Vanden Berghe T."/>
<person name="Cornelis S."/>
<person name="Vandenabeele P."/>
</authorList>
<dbReference type="PubMed" id="17301840"/>
<dbReference type="DOI" id="10.1038/sj.cdd.4402085"/>
</citation>
<scope>REVIEW</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2007" name="J. Biol. Chem." volume="282" first="14788" last="14796">
<title>RIP1-mediated AIP1 phosphorylation at a 14-3-3-binding site is critical for tumor necrosis factor-induced ASK1-JNK/p38 activation.</title>
<authorList>
<person name="Zhang H."/>
<person name="Zhang H."/>
<person name="Lin Y."/>
<person name="Li J."/>
<person name="Pober J.S."/>
<person name="Min W."/>
</authorList>
<dbReference type="PubMed" id="17389591"/>
<dbReference type="DOI" id="10.1074/jbc.m701148200"/>
</citation>
<scope>FUNCTION IN PHOSPHORYLATION OF DAB2IP</scope>
<scope>INTERACTION WITH DAB2IP</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2007" name="J. Biol. Chem." volume="282" first="16776" last="16782">
<title>RBCK1 negatively regulates tumor necrosis factor- and interleukin-1-triggered NF-kappaB activation by targeting TAB2/3 for degradation.</title>
<authorList>
<person name="Tian Y."/>
<person name="Zhang Y."/>
<person name="Zhong B."/>
<person name="Wang Y.Y."/>
<person name="Diao F.C."/>
<person name="Wang R.P."/>
<person name="Zhang M."/>
<person name="Chen D.Y."/>
<person name="Zhai Z.H."/>
<person name="Shu H.B."/>
</authorList>
<dbReference type="PubMed" id="17449468"/>
<dbReference type="DOI" id="10.1074/jbc.m701913200"/>
</citation>
<scope>INTERACTION WITH RBCK1</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2008" name="Curr. Biol." volume="18" first="641" last="649">
<title>CARP-2 is an endosome-associated ubiquitin ligase for RIP and regulates TNF-induced NF-kappaB activation.</title>
<authorList>
<person name="Liao W."/>
<person name="Xiao Q."/>
<person name="Tchikov V."/>
<person name="Fujita K."/>
<person name="Yang W."/>
<person name="Wincovitch S."/>
<person name="Garfield S."/>
<person name="Conze D."/>
<person name="El-Deiry W.S."/>
<person name="Schuetze S."/>
<person name="Srinivasula S.M."/>
</authorList>
<dbReference type="PubMed" id="18450452"/>
<dbReference type="DOI" id="10.1016/j.cub.2008.04.017"/>
</citation>
<scope>INTERACTION WITH RFFL</scope>
<scope>UBIQUITINATION BY RFFL</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2008" name="Nat. Chem. Biol." volume="4" first="313" last="321">
<title>Identification of RIP1 kinase as a specific cellular target of necrostatins.</title>
<authorList>
<person name="Degterev A."/>
<person name="Hitomi J."/>
<person name="Germscheid M."/>
<person name="Ch'en I.L."/>
<person name="Korkina O."/>
<person name="Teng X."/>
<person name="Abbott D."/>
<person name="Cuny G.D."/>
<person name="Yuan C."/>
<person name="Wagner G."/>
<person name="Hedrick S.M."/>
<person name="Gerber S.A."/>
<person name="Lugovskoy A."/>
<person name="Yuan J."/>
</authorList>
<dbReference type="PubMed" id="18408713"/>
<dbReference type="DOI" id="10.1038/nchembio.83"/>
</citation>
<scope>MUTAGENESIS OF SER-161</scope>
<scope>INHIBITION BY NECROSTATIN-1</scope>
<scope>PHOSPHORYLATION AT SER-6; SER-20; SER-25; SER-161; SER-166; SER-303; SER-320 AND SER-333</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2008" name="J. Biol. Chem." volume="283" first="16966" last="16970">
<title>Cytomegalovirus M45 cell death suppression requires receptor-interacting protein (RIP) homotypic interaction motif (RHIM)-dependent interaction with RIP1.</title>
<authorList>
<person name="Upton J.W."/>
<person name="Kaiser W.J."/>
<person name="Mocarski E.S."/>
</authorList>
<dbReference type="PubMed" id="18442983"/>
<dbReference type="DOI" id="10.1074/jbc.c800051200"/>
</citation>
<scope>INTERACTION WITH MURID HERPESVIRUS 1 PROTEIN RIR1</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-320</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="31">
<citation type="journal article" date="2009" name="Cell" volume="137" first="1112" last="1123">
<title>Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation.</title>
<authorList>
<person name="Cho Y.S."/>
<person name="Challa S."/>
<person name="Moquin D."/>
<person name="Genga R."/>
<person name="Ray T.D."/>
<person name="Guildford M."/>
<person name="Chan F.K."/>
</authorList>
<dbReference type="PubMed" id="19524513"/>
<dbReference type="DOI" id="10.1016/j.cell.2009.05.037"/>
</citation>
<scope>FUNCTION</scope>
<scope>PHOSPHORYLATION</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2009" name="Cell" volume="137" first="1100" last="1111">
<title>Receptor interacting protein kinase-3 determines cellular necrotic response to TNF-alpha.</title>
<authorList>
<person name="He S."/>
<person name="Wang L."/>
<person name="Miao L."/>
<person name="Wang T."/>
<person name="Du F."/>
<person name="Zhao L."/>
<person name="Wang X."/>
</authorList>
<dbReference type="PubMed" id="19524512"/>
<dbReference type="DOI" id="10.1016/j.cell.2009.05.021"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH RIPK3</scope>
</reference>
<reference key="33">
<citation type="journal article" date="2009" name="Curr. Biol." volume="19" first="R17" last="R19">
<title>Response: CARP1 regulates induction of NF-kappaB by TNFalpha.</title>
<authorList>
<person name="Liao W."/>
<person name="Fujita K."/>
<person name="Xiao Q."/>
<person name="Tchikov V."/>
<person name="Yang W."/>
<person name="Gunsor M."/>
<person name="Garfield S."/>
<person name="Goldsmith P."/>
<person name="El-Deiry W.S."/>
<person name="Schuetze S."/>
<person name="Srinivasula S.M."/>
</authorList>
<dbReference type="DOI" id="10.1016/j.cub.2008.11.041"/>
</citation>
<scope>INTERACTION WITH RNF34</scope>
<scope>UBIQUITINATION BY RNF34</scope>
</reference>
<reference key="34">
<citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RE4" last="RE4">
<title>The role of the kinases RIP1 and RIP3 in TNF-induced necrosis.</title>
<authorList>
<person name="Vandenabeele P."/>
<person name="Declercq W."/>
<person name="Van Herreweghe F."/>
<person name="Vanden Berghe T."/>
</authorList>
<dbReference type="PubMed" id="20354226"/>
<dbReference type="DOI" id="10.1126/scisignal.3115re4"/>
</citation>
<scope>REVIEW</scope>
</reference>
<reference key="35">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="36">
<citation type="journal article" date="2011" name="Nature" volume="471" first="591" last="596">
<title>Linear ubiquitination prevents inflammation and regulates immune signalling.</title>
<authorList>
<person name="Gerlach B."/>
<person name="Cordier S.M."/>
<person name="Schmukle A.C."/>
<person name="Emmerich C.H."/>
<person name="Rieser E."/>
<person name="Haas T.L."/>
<person name="Webb A.I."/>
<person name="Rickard J.A."/>
<person name="Anderton H."/>
<person name="Wong W.W."/>
<person name="Nachbur U."/>
<person name="Gangoda L."/>
<person name="Warnken U."/>
<person name="Purcell A.W."/>
<person name="Silke J."/>
<person name="Walczak H."/>
</authorList>
<dbReference type="PubMed" id="21455173"/>
<dbReference type="DOI" id="10.1038/nature09816"/>
</citation>
<scope>UBIQUITINATION BY THE LUBAC COMPLEX</scope>
</reference>
<reference key="37">
<citation type="journal article" date="2011" name="PLoS ONE" volume="6" first="E22356" last="E22356">
<title>cIAP1/2 are direct E3 ligases conjugating diverse types of ubiquitin chains to receptor interacting proteins kinases 1 to 4 (RIP1-4).</title>
<authorList>
<person name="Bertrand M.J."/>
<person name="Lippens S."/>
<person name="Staes A."/>
<person name="Gilbert B."/>
<person name="Roelandt R."/>
<person name="De Medts J."/>
<person name="Gevaert K."/>
<person name="Declercq W."/>
<person name="Vandenabeele P."/>
</authorList>
<dbReference type="PubMed" id="21931591"/>
<dbReference type="DOI" id="10.1371/journal.pone.0022356"/>
</citation>
<scope>UBIQUITINATION BY BIRC2/C-IAP1 AND BIRC3/C-IAP2</scope>
<scope>INTERACTION WITH BIRC2/C-IAP1; BIRC3/C-IAP2 AND XIAP/BIRC4</scope>
</reference>
<reference key="38">
<citation type="journal article" date="2012" name="Cell" volume="148" first="228" last="243">
<title>The mitochondrial phosphatase PGAM5 functions at the convergence point of multiple necrotic death pathways.</title>
<authorList>
<person name="Wang Z."/>
<person name="Jiang H."/>
<person name="Chen S."/>
<person name="Du F."/>
<person name="Wang X."/>
</authorList>
<dbReference type="PubMed" id="22265414"/>
<dbReference type="DOI" id="10.1016/j.cell.2011.11.030"/>
</citation>
<scope>IDENTIFICATION IN COMPLEX WITH PGAM5; RIPK3 AND MLKL</scope>
</reference>
<reference key="39">
<citation type="journal article" date="2012" name="Inflamm. Bowel Dis." volume="18" first="603" last="612">
<title>Control of NOD2 and Rip2-dependent innate immune activation by GEF-H1.</title>
<authorList>
<person name="Zhao Y."/>
<person name="Alonso C."/>
<person name="Ballester I."/>
<person name="Song J.H."/>
<person name="Chang S.Y."/>
<person name="Guleng B."/>
<person name="Arihiro S."/>
<person name="Murray P.J."/>
<person name="Xavier R."/>
<person name="Kobayashi K.S."/>
<person name="Reinecker H.C."/>
</authorList>
<dbReference type="PubMed" id="21887730"/>
<dbReference type="DOI" id="10.1002/ibd.21851"/>
</citation>
<scope>INTERACTION WITH ARHGEF2</scope>
</reference>
<reference key="40">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-320</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="41">
<citation type="journal article" date="2014" name="Carcinogenesis" volume="35" first="624" last="634">
<title>SH3RF2 functions as an oncogene by mediating PAK4 protein stability.</title>
<authorList>
<person name="Kim T.W."/>
<person name="Kang Y.K."/>
<person name="Park Z.Y."/>
<person name="Kim Y.H."/>
<person name="Hong S.W."/>
<person name="Oh S.J."/>
<person name="Sohn H.A."/>
<person name="Yang S.J."/>
<person name="Jang Y.J."/>
<person name="Lee D.C."/>
<person name="Kim S.Y."/>
<person name="Yoo H.S."/>
<person name="Kim E."/>
<person name="Yeom Y.I."/>
<person name="Park K.C."/>
</authorList>
<dbReference type="PubMed" id="24130170"/>
<dbReference type="DOI" id="10.1093/carcin/bgt338"/>
</citation>
<scope>INTERACTION WITH TNFRSF1A</scope>
</reference>
<reference key="42">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="43">
<citation type="journal article" date="2014" name="Mol. Cell" volume="56" first="469" last="480">
<title>The two faces of receptor interacting protein kinase-1.</title>
<authorList>
<person name="Weinlich R."/>
<person name="Green D.R."/>
</authorList>
<dbReference type="PubMed" id="25459879"/>
<dbReference type="DOI" id="10.1016/j.molcel.2014.11.001"/>
</citation>
<scope>REVIEW</scope>
</reference>
<reference key="44">
<citation type="journal article" date="2015" name="EMBO Rep." volume="16" first="447" last="455">
<title>WDFY1 mediates TLR3/4 signaling by recruiting TRIF.</title>
<authorList>
<person name="Hu Y.H."/>
<person name="Zhang Y."/>
<person name="Jiang L.Q."/>
<person name="Wang S."/>
<person name="Lei C.Q."/>
<person name="Sun M.S."/>
<person name="Shu H.B."/>
<person name="Liu Y."/>
</authorList>
<dbReference type="PubMed" id="25736436"/>
<dbReference type="DOI" id="10.15252/embr.201439637"/>
</citation>
<scope>INTERACTION WITH TICAM1</scope>
</reference>
<reference key="45">
<citation type="journal article" date="2017" name="J. Virol." volume="91">
<title>Mumps virus SH protein inhibits NF-kappaB activation by interacting with tumor necrosis factor receptor 1, interleukin-1 receptor 1, and Toll-like receptor 3 complexes.</title>
<authorList>
<person name="Franz S."/>
<person name="Rennert P."/>
<person name="Woznik M."/>
<person name="Gruetzke J."/>
<person name="Luedde A."/>
<person name="Arriero Pais E.M."/>
<person name="Finsterbusch T."/>
<person name="Geyer H."/>
<person name="Mankertz A."/>
<person name="Friedrich N."/>
</authorList>
<dbReference type="PubMed" id="28659487"/>
<dbReference type="DOI" id="10.1128/jvi.01037-17"/>
</citation>
<scope>INTERACTION WITH MUMPS VIRUS PROTEIN SH</scope>
</reference>
<reference key="46">
<citation type="journal article" date="2018" name="Mol. Cell" volume="70" first="920" last="935">
<title>PELI1 selectively targets kinase-active RIP3 for ubiquitylation-dependent proteasomal degradation.</title>
<authorList>
<person name="Choi S.W."/>
<person name="Park H.H."/>
<person name="Kim S."/>
<person name="Chung J.M."/>
<person name="Noh H.J."/>
<person name="Kim S.K."/>
<person name="Song H.K."/>
<person name="Lee C.W."/>
<person name="Morgan M.J."/>
<person name="Kang H.C."/>
<person name="Kim Y.S."/>
</authorList>
<dbReference type="PubMed" id="29883609"/>
<dbReference type="DOI" id="10.1016/j.molcel.2018.05.016"/>
</citation>
<scope>INTERACTION WITH PELI1 AND RIPK3</scope>
<scope>UBIQUITINATION BY PELI1</scope>
</reference>
<reference key="47">
<citation type="journal article" date="2018" name="Proc. Natl. Acad. Sci. U.S.A." volume="115" first="E2001" last="E2009">
<title>Death-domain dimerization-mediated activation of RIPK1 controls necroptosis and RIPK1-dependent apoptosis.</title>
<authorList>
<person name="Meng H."/>
<person name="Liu Z."/>
<person name="Li X."/>
<person name="Wang H."/>
<person name="Jin T."/>
<person name="Wu G."/>
<person name="Shan B."/>
<person name="Christofferson D.E."/>
<person name="Qi C."/>
<person name="Yu Q."/>
<person name="Li Y."/>
<person name="Yuan J."/>
</authorList>
<dbReference type="PubMed" id="29440439"/>
<dbReference type="DOI" id="10.1073/pnas.1722013115"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBUNIT</scope>
<scope>MUTAGENESIS OF LYS-599</scope>
<scope>PHOSPHORYLATION AT SER-166</scope>
</reference>
<reference key="48">
<citation type="journal article" date="2018" name="Science" volume="361" first="810" last="813">
<title>Biallelic RIPK1 mutations in humans cause severe immunodeficiency, arthritis, and intestinal inflammation.</title>
<authorList>
<person name="Cuchet-Lourenco D."/>
<person name="Eletto D."/>
<person name="Wu C."/>
<person name="Plagnol V."/>
<person name="Papapietro O."/>
<person name="Curtis J."/>
<person name="Ceron-Gutierrez L."/>
<person name="Bacon C.M."/>
<person name="Hackett S."/>
<person name="Alsaleem B."/>
<person name="Maes M."/>
<person name="Gaspar M."/>
<person name="Alisaac A."/>
<person name="Goss E."/>
<person name="AlIdrissi E."/>
<person name="Siegmund D."/>
<person name="Wajant H."/>
<person name="Kumararatne D."/>
<person name="AlZahrani M.S."/>
<person name="Arkwright P.D."/>
<person name="Abinun M."/>
<person name="Doffinger R."/>
<person name="Nejentsev S."/>
</authorList>
<dbReference type="PubMed" id="30026316"/>
<dbReference type="DOI" id="10.1126/science.aar2641"/>
</citation>
<scope>INVOLVEMENT IN IMD57</scope>
</reference>
<reference key="49">
<citation type="journal article" date="2019" name="Front. Cell Dev. Biol." volume="7" first="163" last="163">
<title>Ripoptocide - A Spark for Inflammation.</title>
<authorList>
<person name="Ang R.L."/>
<person name="Chan M."/>
<person name="Ting A.T."/>
</authorList>
<dbReference type="PubMed" id="31457011"/>
<dbReference type="DOI" id="10.3389/fcell.2019.00163"/>
</citation>
<scope>REVIEW</scope>
</reference>
<reference key="50">
<citation type="journal article" date="2019" name="Nat. Commun." volume="10" first="1729" last="1729">
<title>Serine 25 phosphorylation inhibits RIPK1 kinase-dependent cell death in models of infection and inflammation.</title>
<authorList>
<person name="Dondelinger Y."/>
<person name="Delanghe T."/>
<person name="Priem D."/>
<person name="Wynosky-Dolfi M.A."/>
<person name="Sorobetea D."/>
<person name="Rojas-Rivera D."/>
<person name="Giansanti P."/>
<person name="Roelandt R."/>
<person name="Gropengiesser J."/>
<person name="Ruckdeschel K."/>
<person name="Savvides S.N."/>
<person name="Heck A.J.R."/>
<person name="Vandenabeele P."/>
<person name="Brodsky I.E."/>
<person name="Bertrand M.J.M."/>
</authorList>
<dbReference type="PubMed" id="30988283"/>
<dbReference type="DOI" id="10.1038/s41467-019-09690-0"/>
</citation>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>PHOSPHORYLATION AT SER-25</scope>
<scope>MUTAGENESIS OF SER-25 AND LYS-45</scope>
</reference>
<reference key="51">
<citation type="journal article" date="2013" name="Structure" volume="21" first="493" last="499">
<title>Structural basis of RIP1 inhibition by necrostatins.</title>
<authorList>
<person name="Xie T."/>
<person name="Peng W."/>
<person name="Liu Y."/>
<person name="Yan C."/>
<person name="Maki J."/>
<person name="Degterev A."/>
<person name="Yuan J."/>
<person name="Shi Y."/>
</authorList>
<dbReference type="PubMed" id="23473668"/>
<dbReference type="DOI" id="10.1016/j.str.2013.01.016"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS) OF 1-294 IN COMPLEXES WITH NECROSTATIN-TYPE INHIBITORS</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>ACTIVITY REGULATION</scope>
<scope>AUTOPHOSPHORYLATION</scope>
</reference>
<reference key="52">
<citation type="journal article" date="2007" name="Nature" volume="446" first="153" last="158">
<title>Patterns of somatic mutation in human cancer genomes.</title>
<authorList>
<person name="Greenman C."/>
<person name="Stephens P."/>
<person name="Smith R."/>
<person name="Dalgliesh G.L."/>
<person name="Hunter C."/>
<person name="Bignell G."/>
<person name="Davies H."/>
<person name="Teague J."/>
<person name="Butler A."/>
<person name="Stevens C."/>
<person name="Edkins S."/>
<person name="O'Meara S."/>
<person name="Vastrik I."/>
<person name="Schmidt E.E."/>
<person name="Avis T."/>
<person name="Barthorpe S."/>
<person name="Bhamra G."/>
<person name="Buck G."/>
<person name="Choudhury B."/>
<person name="Clements J."/>
<person name="Cole J."/>
<person name="Dicks E."/>
<person name="Forbes S."/>
<person name="Gray K."/>
<person name="Halliday K."/>
<person name="Harrison R."/>
<person name="Hills K."/>
<person name="Hinton J."/>
<person name="Jenkinson A."/>
<person name="Jones D."/>
<person name="Menzies A."/>
<person name="Mironenko T."/>
<person name="Perry J."/>
<person name="Raine K."/>
<person name="Richardson D."/>
<person name="Shepherd R."/>
<person name="Small A."/>
<person name="Tofts C."/>
<person name="Varian J."/>
<person name="Webb T."/>
<person name="West S."/>
<person name="Widaa S."/>
<person name="Yates A."/>
<person name="Cahill D.P."/>
<person name="Louis D.N."/>
<person name="Goldstraw P."/>
<person name="Nicholson A.G."/>
<person name="Brasseur F."/>
<person name="Looijenga L."/>
<person name="Weber B.L."/>
<person name="Chiew Y.-E."/>
<person name="DeFazio A."/>
<person name="Greaves M.F."/>
<person name="Green A.R."/>
<person name="Campbell P."/>
<person name="Birney E."/>
<person name="Easton D.F."/>
<person name="Chenevix-Trench G."/>
<person name="Tan M.-H."/>
<person name="Khoo S.K."/>
<person name="Teh B.T."/>
<person name="Yuen S.T."/>
<person name="Leung S.Y."/>
<person name="Wooster R."/>
<person name="Futreal P.A."/>
<person name="Stratton M.R."/>
</authorList>
<dbReference type="PubMed" id="17344846"/>
<dbReference type="DOI" id="10.1038/nature05610"/>
</citation>
<scope>VARIANTS [LARGE SCALE ANALYSIS] VAL-64; ILE-81; VAL-220; SER-404; VAL-443 AND VAL-569</scope>
</reference>
<comment type="function">
<text evidence="14 24 34 39 40 49 52 60 61">Serine-threonine kinase which is a key regulator of both cell death and cell survival (PubMed:25459879). Exhibits kinase activity-dependent functions that trigger cell death and kinase-independent scaffold functions regulating inflammatory signaling and cell survival (PubMed:11101870, PubMed:25459879). Initiates ripoptocide which describes cell death that is dependent on RIPK1, be it apoptosis or necroptosis (PubMed:31457011). Upon binding of TNF to TNFR1, RIPK1 is recruited to the TNF-R1 signaling complex (TNF-RSC also known as complex I) where it acts as a scaffold protein promoting cell survival, in part, by activating the canonical NF-kB pathway (By similarity). Specific conditions can however activate RIPK1, and its kinase activity then regulates assembly of two death-inducing complexes, namely complex IIa (RIPK1-FADD-CASP8) and the complex IIb (RIPK1-RIPK3-MLKL) and these complexes respectively drive apoptosis or necroptosis, a regulated form of necrosis (PubMed:19524513, PubMed:19524512, PubMed:29440439, PubMed:30988283). During embryonic development suppresses apoptosis and necroptosis and prevents the interaction of TRADD with FADD thereby limiting aberrant activation of CASP8 (By similarity). Phosphorylates DAB2IP at 'Ser-728' in a TNF- alpha-dependent manner, and thereby activates the MAP3K5-JNK apoptotic cascade (PubMed:17389591). Required for ZBP1-induced NF-kappaB activation and activation of NF-kappaB by DNA damage and IR (By similarity).</text>
</comment>
<comment type="catalytic activity">
<reaction evidence="45 52">
<text>ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-[protein]</text>
<dbReference type="Rhea" id="RHEA:17989"/>
<dbReference type="Rhea" id="RHEA-COMP:9863"/>
<dbReference type="Rhea" id="RHEA-COMP:11604"/>
<dbReference type="ChEBI" id="CHEBI:15378"/>
<dbReference type="ChEBI" id="CHEBI:29999"/>
<dbReference type="ChEBI" id="CHEBI:30616"/>
<dbReference type="ChEBI" id="CHEBI:83421"/>
<dbReference type="ChEBI" id="CHEBI:456216"/>
<dbReference type="EC" id="2.7.11.1"/>
</reaction>
</comment>
<comment type="catalytic activity">
<reaction evidence="45 52">
<text>ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-threonyl-[protein]</text>
<dbReference type="Rhea" id="RHEA:46608"/>
<dbReference type="Rhea" id="RHEA-COMP:11060"/>
<dbReference type="Rhea" id="RHEA-COMP:11605"/>
<dbReference type="ChEBI" id="CHEBI:15378"/>
<dbReference type="ChEBI" id="CHEBI:30013"/>
<dbReference type="ChEBI" id="CHEBI:30616"/>
<dbReference type="ChEBI" id="CHEBI:61977"/>
<dbReference type="ChEBI" id="CHEBI:456216"/>
<dbReference type="EC" id="2.7.11.1"/>
</reaction>
</comment>
<comment type="activity regulation">
<text evidence="14 45">Serine-threonine kinase activity is inhibited by linear polyubiquitination ('Met-1'-linked) by the LUBAC complex (By similarity). Inhibited by necrostatins, including necrostatin-1, necrostatin-3 and necrostatin-4 (PubMed:23473668).</text>
</comment>
<comment type="subunit">
<text evidence="14 20 21 22 25 26 27 28 31 34 35 38 39 42 43 44 46 47 49 50 54 55 56 57">Homodimer (PubMed:29440439). Interacts (via RIP homotypic interaction motif) with RIPK3 (via RIP homotypic interaction motif); this interaction induces RIPK1 phosphorylation and formation of a RIPK1-RIPK3 necroptosis-inducing complex (PubMed:11734559, PubMed:29883609, PubMed:19524512, PubMed:10358032). Upon TNF-induced necrosis, the RIPK1-RIPK3 dimer further interacts with PGAM5 and MLKL; the formation of this complex leads to PGAM5 phosphorylation and increase in PGAM5 phosphatase activity (PubMed:22265414). Interacts (via the death domain) with TNFRSF6 (via the death domain) and TRADD (via the death domain) (PubMed:8612133). Is recruited by TRADD to TNFRSF1A in a TNF-dependent process (PubMed:24130170). Binds RNF216, EGFR, IKBKG, TRAF1, TRAF2 and TRAF3 (PubMed:8612133, PubMed:9927690, PubMed:11854271, PubMed:11116146). Interacts with BNLF1 (PubMed:10409763). Interacts with SQSTM1 upon TNF-alpha stimulation (PubMed:10356400). May interact with MAVS/IPS1 (PubMed:16127453). Interacts with ZFAND5 (PubMed:14754897). Interacts with RBCK1 (PubMed:17449468). Interacts with ZBP1 (By similarity). Interacts with BIRC2/c-IAP1, BIRC3/c-IAP2 and XIAP/BIRC4 (PubMed:21931591). Interacts (via kinase domain) with DAB2IP (via Ras-GAP domain); the interaction occurs in a TNF-alpha-dependent manner (PubMed:17389591). Interacts with ARHGEF2 (PubMed:21887730). Interacts (via protein kinase domain) with RFFL; involved in RIPK1 ubiquitination (PubMed:18450452). Interacts with RNF34; involved in RIPK1 ubiquitination (Ref.33). Interacts with TICAM1 and this interaction is enhanced in the presence of WDFY1 (PubMed:25736436). Interacts with PELI1 (PubMed:29883609). Interacts (via death domain) with CRADD (via death domain); the interaction is direct (PubMed:9044836). Component of complex IIa composed of at least RIPK1, FADD and CASP8 (By similarity). Interacts with MAP3K7, CFLAR, CASP8, FADD and NEMO (By similarity).</text>
</comment>
<comment type="subunit">
<text evidence="48">(Microbial infection) Interacts with mumps virus protein SH; this interaction inhibits downstream NF-kappa-B pathway activation.</text>
</comment>
<comment type="subunit">
<text evidence="37">(Microbial infection) Interacts with Murid herpesvirus 1 protein RIR1.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-358507">
<id>Q13546</id>
</interactant>
<interactant intactId="EBI-358507">
<id>Q13546</id>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>10</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-358507">
<id>Q13546</id>
</interactant>
<interactant intactId="EBI-354007">
<id>P04083</id>
<label>ANXA1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-358507">
<id>Q13546</id>
</interactant>
<interactant intactId="EBI-514538">
<id>Q13490</id>
<label>BIRC2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-358507">
<id>Q13546</id>
</interactant>
<interactant intactId="EBI-517709">
<id>Q13489</id>
<label>BIRC3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-358507">
<id>Q13546</id>
</interactant>
<interactant intactId="EBI-495095">
<id>Q92851</id>
<label>CASP10</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-358507">
<id>Q13546</id>
</interactant>
<interactant intactId="EBI-78060">
<id>Q14790</id>
<label>CASP8</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>27</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-358507">
<id>Q13546</id>
</interactant>
<interactant intactId="EBI-723996">
<id>Q8IVM0</id>
<label>CCDC50</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-358507">
<id>Q13546</id>
</interactant>
<interactant intactId="EBI-1383726">
<id>P48729</id>
<label>CSNK1A1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-358507">
<id>Q13546</id>
</interactant>
<interactant intactId="EBI-16070376">
<id>B7UI21</id>
<label>E2348C_3231</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-358507">
<id>Q13546</id>
</interactant>
<interactant intactId="EBI-494804">
<id>Q13158</id>
<label>FADD</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>10</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-358507">
<id>Q13546</id>
</interactant>
<interactant intactId="EBI-81279">
<id>Q9Y6K9</id>
<label>IKBKG</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>8</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-358507">
<id>Q13546</id>
</interactant>
<interactant intactId="EBI-751215">
<id>Q9ULZ3</id>
<label>PYCARD</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-358507">
<id>Q13546</id>
</interactant>
<interactant intactId="EBI-298250">
<id>Q9Y572</id>
<label>RIPK3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>26</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-358507">
<id>Q13546</id>
</interactant>
<interactant intactId="EBI-299451">
<id>P19438</id>
<label>TNFRSF1A</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-358507">
<id>Q13546</id>
</interactant>
<interactant intactId="EBI-359224">
<id>Q13077</id>
<label>TRAF1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-358507">
<id>Q13546</id>
</interactant>
<interactant intactId="EBI-355744">
<id>Q12933</id>
<label>TRAF2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>8</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-358507">
<id>Q13546</id>
</interactant>
<interactant intactId="EBI-357631">
<id>Q13114</id>
<label>TRAF3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-358507">
<id>Q13546</id>
</interactant>
<interactant intactId="EBI-11894787">
<id>U5TQE9</id>
<label>UL39</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-358507">
<id>Q13546</id>
</interactant>
<interactant intactId="EBI-723290">
<id>Q13107</id>
<label>USP4</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="14">Cytoplasm</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="15">Cell membrane</location>
</subcellularLocation>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>Q13546-1</id>
<name>1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>Q13546-2</id>
<name>2</name>
<sequence type="described" ref="VSP_037690"/>
</isoform>
</comment>
<comment type="domain">
<text evidence="20 49">The death domain mediates dimerization and activation of its kinase activity during necroptosis and apoptosis (PubMed:29440439). It engages other DD-containing proteins as well as a central (intermediate) region important for NF-kB activation and RHIM-dependent signaling (PubMed:10356400).</text>
</comment>
<comment type="PTM">
<text evidence="14 23">Proteolytically cleaved by CASP8 at Asp-324 (PubMed:10521396). Cleavage is crucial for limiting apoptosis and necroptosis during embryonic development (By similarity). Cleavage abolishes NF-kappa-B activation and enhances the interaction of TRADD with FADD (PubMed:10521396).</text>
</comment>
<comment type="PTM">
<text evidence="14 36 40 52">RIPK1 and RIPK3 undergo reciprocal auto- and trans-phosphorylation (PubMed:18408713, PubMed:19524513). Phosphorylation of Ser-161 by RIPK3 is necessary for the formation of the necroptosis-inducing complex (PubMed:18408713). Phosphorylation at Ser-25 represses its kinase activity and consequently prevents TNF-mediated RIPK1-dependent cell death (PubMed:30988283). Phosphorylated at Ser-320 by MAP3K7 which requires prior ubiquitination with 'Lys-63'-linked chains by BIRC2/c-IAP1 and BIRC3/c-IAP2 (By similarity). This phosphorylation positively regulates RIPK1 interaction with RIPK3 to promote necroptosis but negatively regulates RIPK1 kinase activity and its interaction with FADD to mediate apoptosis (By similarity).</text>
</comment>
<comment type="PTM">
<text evidence="14 29 32 38 41 43 50 57">Ubiquitinated with 'Lys-11'-, 'Lys-48'-, 'Lys-63'- and linear-linked type ubiquitin (PubMed:15258597, PubMed:16603398, PubMed:18450452, PubMed:21455173, PubMed:21931591, PubMed:29883609, Ref.33). Polyubiquitination with 'Lys-63'-linked chains by TRAF2 induces association with the IKK complex (PubMed:15258597). Deubiquitination of 'Lys-63'-linked chains and polyubiquitination with 'Lys-48'-linked chains by TNFAIP3 leads to RIPK1 proteasomal degradation and consequently down-regulates TNF-alpha-induced NFkappa-B signaling (PubMed:15258597). 'Lys-48'-linked polyubiquitination by RFFL or RNF34 also promotes proteasomal degradation and negatively regulates TNF-alpha-induced NF-kappa-B signaling (PubMed:18450452, Ref.33). Linear polyubiquitinated; the head-to-tail linear polyubiquitination ('Met-1'-linked) is mediated by the LUBAC complex and decreases protein kinase activity (PubMed:21455173). Deubiquitination of linear polyubiquitin by CYLD promotes the kinase activity (By similarity). Polyubiquitinated with 'Lys-48' and 'Lys-63'-linked chains by BIRC2/c-IAP1 and BIRC3/c-IAP2, leading to activation of NF-kappa-B (PubMed:21931591). Ubiquitinated with 'Lys-63'-linked chains by PELI1 (PubMed:29883609). Ubiquitination at Lys-377 with 'Lys-63'-linked chains by BIRC2/c-IAP1 and BIRC3/c-IAP2 is essential for its phosphorylation at Ser-320 mediated by MAP3K7 (By similarity). This ubiquitination is required for NF-kB activation, suppresses RIPK1 kinase activity and plays a critical role in preventing cell death during embryonic development (By similarity).</text>
</comment>
<comment type="disease" evidence="51">
<disease id="DI-05328">
<name>Immunodeficiency 57</name>
<acronym>IMD57</acronym>
<description>An autosomal recessive primary immunodeficiency characterized by lymphopenia and recurrent viral, bacterial, and fungal infections. Patients exhibit early-onset inflammatory bowel disease involving the upper and lower gastrointestinal tract, and develop progressive polyarthritis.</description>
<dbReference type="MIM" id="618108"/>
</disease>
<text evidence="51">The disease is caused by mutations affecting the gene represented in this entry. RIPK1-deficient immune cells from IMD57 patients have impaired proinflammatory signaling leading to dysregulated cytokine secretion and are prone to necroptosis.</text>
</comment>
<comment type="similarity">
<text evidence="62">Belongs to the protein kinase superfamily. TKL Ser/Thr protein kinase family.</text>
</comment>
<comment type="sequence caution" evidence="62">
<conflict type="erroneous initiation">
<sequence resource="EMBL-CDS" id="BAG65471" version="1"/>
</conflict>
</comment>
<comment type="online information" name="SeattleSNPs">
<link uri="http://pga.gs.washington.edu/data/ripk1/"/>
</comment>
<dbReference type="EC" id="2.7.11.1" evidence="45 52"/>
<dbReference type="EMBL" id="U50062">
<property type="protein sequence ID" value="AAC32232.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK314176">
<property type="protein sequence ID" value="BAG36858.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK304701">
<property type="protein sequence ID" value="BAG65471.1"/>
<property type="status" value="ALT_INIT"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY682848">
<property type="protein sequence ID" value="AAT74626.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL031963">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC126254">
<property type="protein sequence ID" value="AAI26255.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC126256">
<property type="protein sequence ID" value="AAI26257.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AB208926">
<property type="protein sequence ID" value="BAD92163.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U25994">
<property type="protein sequence ID" value="AAC50137.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS4482.1">
<molecule id="Q13546-1"/>
</dbReference>
<dbReference type="PIR" id="T09479">
<property type="entry name" value="T09479"/>
</dbReference>
<dbReference type="RefSeq" id="NP_003795.2">
<molecule id="Q13546-1"/>
<property type="nucleotide sequence ID" value="NM_003804.4"/>
</dbReference>
<dbReference type="RefSeq" id="XP_005249514.2">
<property type="nucleotide sequence ID" value="XM_005249457.3"/>
</dbReference>
<dbReference type="PDB" id="4ITH">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.25"/>
<property type="chains" value="A/B=1-294"/>
</dbReference>
<dbReference type="PDB" id="4ITI">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.86"/>
<property type="chains" value="A/B=1-294"/>
</dbReference>
<dbReference type="PDB" id="4ITJ">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.80"/>
<property type="chains" value="A/B=1-294"/>
</dbReference>
<dbReference type="PDB" id="4NEU">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.57"/>
<property type="chains" value="A/B=1-324"/>
</dbReference>
<dbReference type="PDB" id="5HX6">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.23"/>
<property type="chains" value="A/B=1-294"/>
</dbReference>
<dbReference type="PDB" id="5TX5">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.56"/>
<property type="chains" value="A/B=1-294"/>
</dbReference>
<dbReference type="PDB" id="5V7Z">
<property type="method" value="NMR"/>
<property type="chains" value="B/D/F/H=532-549"/>
</dbReference>
<dbReference type="PDB" id="6AC5">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.45"/>
<property type="chains" value="A=561-671"/>
</dbReference>
<dbReference type="PDB" id="6C3E">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.60"/>
<property type="chains" value="A/B=2-294"/>
</dbReference>
<dbReference type="PDB" id="6C4D">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.52"/>
<property type="chains" value="A/B/C/D=2-294"/>
</dbReference>
<dbReference type="PDB" id="6HHO">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.49"/>
<property type="chains" value="A/B=1-294"/>
</dbReference>
<dbReference type="PDB" id="6NW2">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="A/B=1-294"/>
</dbReference>
<dbReference type="PDB" id="6NYH">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.10"/>
<property type="chains" value="A/B=1-294"/>
</dbReference>
<dbReference type="PDB" id="6OCQ">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.79"/>
<property type="chains" value="A/B=1-294"/>
</dbReference>
<dbReference type="PDB" id="6R5F">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.25"/>
<property type="chains" value="A/B/C/D=1-294"/>
</dbReference>
<dbReference type="PDB" id="6RLN">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.87"/>
<property type="chains" value="A/B=1-294"/>
</dbReference>
<dbReference type="PDBsum" id="4ITH"/>
<dbReference type="PDBsum" id="4ITI"/>
<dbReference type="PDBsum" id="4ITJ"/>
<dbReference type="PDBsum" id="4NEU"/>
<dbReference type="PDBsum" id="5HX6"/>
<dbReference type="PDBsum" id="5TX5"/>
<dbReference type="PDBsum" id="5V7Z"/>
<dbReference type="PDBsum" id="6AC5"/>
<dbReference type="PDBsum" id="6C3E"/>
<dbReference type="PDBsum" id="6C4D"/>
<dbReference type="PDBsum" id="6HHO"/>
<dbReference type="PDBsum" id="6NW2"/>
<dbReference type="PDBsum" id="6NYH"/>
<dbReference type="PDBsum" id="6OCQ"/>
<dbReference type="PDBsum" id="6R5F"/>
<dbReference type="PDBsum" id="6RLN"/>
<dbReference type="SMR" id="Q13546"/>
<dbReference type="BioGrid" id="114274">
<property type="interactions" value="101"/>
</dbReference>
<dbReference type="ComplexPortal" id="CPX-1907">
<property type="entry name" value="Ripoptosome"/>
</dbReference>
<dbReference type="CORUM" id="Q13546"/>
<dbReference type="DIP" id="DIP-433N"/>
<dbReference type="IntAct" id="Q13546">
<property type="interactions" value="74"/>
</dbReference>
<dbReference type="MINT" id="Q13546"/>
<dbReference type="STRING" id="9606.ENSP00000259808"/>
<dbReference type="BindingDB" id="Q13546"/>
<dbReference type="ChEMBL" id="CHEMBL5464"/>
<dbReference type="DrugBank" id="DB12010">
<property type="generic name" value="Fostamatinib"/>
</dbReference>
<dbReference type="DrugCentral" id="Q13546"/>
<dbReference type="GuidetoPHARMACOLOGY" id="2189"/>
<dbReference type="iPTMnet" id="Q13546"/>
<dbReference type="MetOSite" id="Q13546"/>
<dbReference type="PhosphoSitePlus" id="Q13546"/>
<dbReference type="BioMuta" id="RIPK1"/>
<dbReference type="DMDM" id="60393639"/>
<dbReference type="CPTAC" id="CPTAC-1053"/>
<dbReference type="CPTAC" id="CPTAC-900"/>
<dbReference type="CPTAC" id="CPTAC-901"/>
<dbReference type="CPTAC" id="CPTAC-902"/>
<dbReference type="EPD" id="Q13546"/>
<dbReference type="jPOST" id="Q13546"/>
<dbReference type="MassIVE" id="Q13546"/>
<dbReference type="MaxQB" id="Q13546"/>
<dbReference type="PaxDb" id="Q13546"/>
<dbReference type="PeptideAtlas" id="Q13546"/>
<dbReference type="PRIDE" id="Q13546"/>
<dbReference type="ProteomicsDB" id="59527">
<molecule id="Q13546-1"/>
</dbReference>
<dbReference type="ProteomicsDB" id="59528">
<molecule id="Q13546-2"/>
</dbReference>
<dbReference type="Antibodypedia" id="4145">
<property type="antibodies" value="591 antibodies"/>
</dbReference>
<dbReference type="DNASU" id="8737"/>
<dbReference type="Ensembl" id="ENST00000259808">
<molecule id="Q13546-1"/>
<property type="protein sequence ID" value="ENSP00000259808"/>
<property type="gene ID" value="ENSG00000137275"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000380409">
<molecule id="Q13546-1"/>
<property type="protein sequence ID" value="ENSP00000369773"/>
<property type="gene ID" value="ENSG00000137275"/>
</dbReference>
<dbReference type="GeneID" id="8737"/>
<dbReference type="KEGG" id="hsa:8737"/>
<dbReference type="UCSC" id="uc003mux.4">
<molecule id="Q13546-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="8737"/>
<dbReference type="DisGeNET" id="8737"/>
<dbReference type="GeneCards" id="RIPK1"/>
<dbReference type="HGNC" id="HGNC:10019">
<property type="gene designation" value="RIPK1"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000137275">
<property type="expression patterns" value="Low tissue specificity"/>
</dbReference>
<dbReference type="MalaCards" id="RIPK1"/>
<dbReference type="MIM" id="603453">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="618108">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q13546"/>
<dbReference type="OpenTargets" id="ENSG00000137275"/>
<dbReference type="PharmGKB" id="PA34394"/>
<dbReference type="eggNOG" id="KOG0192">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="COG0515">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00940000159347"/>
<dbReference type="HOGENOM" id="CLU_017229_0_0_1"/>
<dbReference type="InParanoid" id="Q13546"/>
<dbReference type="KO" id="K02861"/>
<dbReference type="OMA" id="NDFHIKI"/>
<dbReference type="OrthoDB" id="346354at2759"/>
<dbReference type="PhylomeDB" id="Q13546"/>
<dbReference type="TreeFam" id="TF106506"/>
<dbReference type="BRENDA" id="2.7.10.2">
<property type="organism ID" value="2681"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-140534">
<property type="pathway name" value="Caspase activation via Death Receptors in the presence of ligand"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-168927">
<property type="pathway name" value="TICAM1, RIP1-mediated IKK complex recruitment"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1810476">
<property type="pathway name" value="RIP-mediated NFkB activation via ZBP1"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2562578">
<property type="pathway name" value="TRIF-mediated programmed cell death"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-3295583">
<property type="pathway name" value="TRP channels"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-3371378">
<property type="pathway name" value="Regulation by c-FLIP"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5213460">
<property type="pathway name" value="RIPK1-mediated regulated necrosis"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5218900">
<property type="pathway name" value="CASP8 activity is inhibited"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5357786">
<property type="pathway name" value="TNFR1-induced proapoptotic signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5357905">
<property type="pathway name" value="Regulation of TNFR1 signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5357956">
<property type="pathway name" value="TNFR1-induced NFkappaB signaling pathway"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5675482">
<property type="pathway name" value="Regulation of necroptotic cell death"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5689880">
<property type="pathway name" value="Ub-specific processing proteases"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5689896">
<property type="pathway name" value="Ovarian tumor domain proteases"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-69416">
<property type="pathway name" value="Dimerization of procaspase-8"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-75893">
<property type="pathway name" value="TNF signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9013957">
<property type="pathway name" value="TLR3-mediated TICAM1-dependent programmed cell death"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-933543">
<property type="pathway name" value="NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-937041">
<property type="pathway name" value="IKK complex recruitment mediated by RIP1"/>
</dbReference>
<dbReference type="SignaLink" id="Q13546"/>
<dbReference type="SIGNOR" id="Q13546"/>
<dbReference type="ChiTaRS" id="RIPK1">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="GeneWiki" id="RIPK1"/>
<dbReference type="GenomeRNAi" id="8737"/>
<dbReference type="Pharos" id="Q13546">
<property type="development level" value="Tchem"/>
</dbReference>
<dbReference type="PRO" id="PR:Q13546"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 6"/>
</dbReference>
<dbReference type="RNAct" id="Q13546">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000137275">
<property type="expression patterns" value="Expressed in right lobe of liver and 183 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="Q13546">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q13546">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0031264">
<property type="term" value="C:death-inducing signaling complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0010008">
<property type="term" value="C:endosome membrane"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0045121">
<property type="term" value="C:membrane raft"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005739">
<property type="term" value="C:mitochondrion"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0032991">
<property type="term" value="C:protein-containing complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043235">
<property type="term" value="C:receptor complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0097342">
<property type="term" value="C:ripoptosome"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005524">
<property type="term" value="F:ATP binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0070513">
<property type="term" value="F:death domain binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005123">
<property type="term" value="F:death receptor binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0042802">
<property type="term" value="F:identical protein binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="IntAct"/>
</dbReference>
<dbReference type="GO" id="GO:0004706">
<property type="term" value="F:JUN kinase kinase kinase activity"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0042803">
<property type="term" value="F:protein homodimerization activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004672">
<property type="term" value="F:protein kinase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004674">
<property type="term" value="F:protein serine/threonine kinase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0044877">
<property type="term" value="F:protein-containing complex binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0031625">
<property type="term" value="F:ubiquitin protein ligase binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006919">
<property type="term" value="P:activation of cysteine-type endopeptidase activity involved in apoptotic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0007257">
<property type="term" value="P:activation of JUN kinase activity"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:1990000">
<property type="term" value="P:amyloid fibril formation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006915">
<property type="term" value="P:apoptotic process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0097190">
<property type="term" value="P:apoptotic signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0008219">
<property type="term" value="P:cell death"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0044257">
<property type="term" value="P:cellular protein catabolic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071363">
<property type="term" value="P:cellular response to growth factor stimulus"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0070301">
<property type="term" value="P:cellular response to hydrogen peroxide"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0071356">
<property type="term" value="P:cellular response to tumor necrosis factor"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071550">
<property type="term" value="P:death-inducing signaling complex assembly"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0097191">
<property type="term" value="P:extrinsic apoptotic signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0007249">
<property type="term" value="P:I-kappaB kinase/NF-kappaB signaling"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0002756">
<property type="term" value="P:MyD88-independent toll-like receptor signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0070266">
<property type="term" value="P:necroptotic process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0097527">
<property type="term" value="P:necroptotic signaling pathway"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0043066">
<property type="term" value="P:negative regulation of apoptotic process"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0060044">
<property type="term" value="P:negative regulation of cardiac muscle cell proliferation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:2001237">
<property type="term" value="P:negative regulation of extrinsic apoptotic signaling pathway"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:2001240">
<property type="term" value="P:negative regulation of extrinsic apoptotic signaling pathway in absence of ligand"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:1902042">
<property type="term" value="P:negative regulation of extrinsic apoptotic signaling pathway via death domain receptors"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:2000134">
<property type="term" value="P:negative regulation of G1/S transition of mitotic cell cycle"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0043124">
<property type="term" value="P:negative regulation of I-kappaB kinase/NF-kappaB signaling"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0036289">
<property type="term" value="P:peptidyl-serine autophosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043065">
<property type="term" value="P:positive regulation of apoptotic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:2001238">
<property type="term" value="P:positive regulation of extrinsic apoptotic signaling pathway"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1905206">
<property type="term" value="P:positive regulation of hydrogen peroxide-induced cell death"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0043123">
<property type="term" value="P:positive regulation of I-kappaB kinase/NF-kappaB signaling"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032757">
<property type="term" value="P:positive regulation of interleukin-8 production"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0046330">
<property type="term" value="P:positive regulation of JNK cascade"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045651">
<property type="term" value="P:positive regulation of macrophage differentiation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0060545">
<property type="term" value="P:positive regulation of necroptotic process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0010940">
<property type="term" value="P:positive regulation of necrotic cell death"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0051092">
<property type="term" value="P:positive regulation of NF-kappaB transcription factor activity"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1903800">
<property type="term" value="P:positive regulation of production of miRNAs involved in gene silencing by miRNA"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0043068">
<property type="term" value="P:positive regulation of programmed cell death"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001934">
<property type="term" value="P:positive regulation of protein phosphorylation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:2000379">
<property type="term" value="P:positive regulation of reactive oxygen species metabolic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0045944">
<property type="term" value="P:positive regulation of transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032760">
<property type="term" value="P:positive regulation of tumor necrosis factor production"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1903265">
<property type="term" value="P:positive regulation of tumor necrosis factor-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0097300">
<property type="term" value="P:programmed necrotic cell death"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0046777">
<property type="term" value="P:protein autophosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0016579">
<property type="term" value="P:protein deubiquitination"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0070926">
<property type="term" value="P:regulation of ATP:ADP antiporter activity"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1902041">
<property type="term" value="P:regulation of extrinsic apoptotic signaling pathway via death domain receptors"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0010803">
<property type="term" value="P:regulation of tumor necrosis factor-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0034612">
<property type="term" value="P:response to tumor necrosis factor"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0097343">
<property type="term" value="P:ripoptosome assembly"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1901026">
<property type="term" value="P:ripoptosome assembly involved in necroptotic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0070231">
<property type="term" value="P:T cell apoptotic process"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0034138">
<property type="term" value="P:toll-like receptor 3 signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0035666">
<property type="term" value="P:TRIF-dependent toll-like receptor signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0033209">
<property type="term" value="P:tumor necrosis factor-mediated signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0016032">
<property type="term" value="P:viral process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="CDD" id="cd08777">
<property type="entry name" value="Death_RIP1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR011029">
<property type="entry name" value="DEATH-like_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR000488">
<property type="entry name" value="Death_domain"/>
</dbReference>
<dbReference type="InterPro" id="IPR011009">
<property type="entry name" value="Kinase-like_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR000719">
<property type="entry name" value="Prot_kinase_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR025735">
<property type="entry name" value="RHIM_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR037934">
<property type="entry name" value="RIP1_Death"/>
</dbReference>
<dbReference type="InterPro" id="IPR001245">
<property type="entry name" value="Ser-Thr/Tyr_kinase_cat_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR008271">
<property type="entry name" value="Ser/Thr_kinase_AS"/>
</dbReference>
<dbReference type="Pfam" id="PF00531">
<property type="entry name" value="Death"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF07714">
<property type="entry name" value="Pkinase_Tyr"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF12721">
<property type="entry name" value="RHIM"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR00109">
<property type="entry name" value="TYRKINASE"/>
</dbReference>
<dbReference type="SMART" id="SM00005">
<property type="entry name" value="DEATH"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00220">
<property type="entry name" value="S_TKc"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF47986">
<property type="entry name" value="SSF47986"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF56112">
<property type="entry name" value="SSF56112"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50017">
<property type="entry name" value="DEATH_DOMAIN"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50011">
<property type="entry name" value="PROTEIN_KINASE_DOM"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00108">
<property type="entry name" value="PROTEIN_KINASE_ST"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0053">Apoptosis</keyword>
<keyword id="KW-0067">ATP-binding</keyword>
<keyword id="KW-1003">Cell membrane</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0945">Host-virus interaction</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-0418">Kinase</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-1210">Necrosis</keyword>
<keyword id="KW-0547">Nucleotide-binding</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0723">Serine/threonine-protein kinase</keyword>
<keyword id="KW-0808">Transferase</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="chain" description="Receptor-interacting serine/threonine-protein kinase 1" id="PRO_0000086606">
<location>
<begin position="1"/>
<end position="671"/>
</location>
</feature>
<feature type="domain" description="Protein kinase" evidence="18">
<location>
<begin position="17"/>
<end position="289"/>
</location>
</feature>
<feature type="domain" description="Death" evidence="17">
<location>
<begin position="583"/>
<end position="669"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="ATP" evidence="18">
<location>
<begin position="23"/>
<end position="31"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with SQSTM1" evidence="20">
<location>
<begin position="290"/>
<end position="582"/>
</location>
</feature>
<feature type="short sequence motif" description="RIP homotypic interaction motif (RHIM)" evidence="26">
<location>
<begin position="531"/>
<end position="547"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Arg">
<location>
<begin position="411"/>
<end position="414"/>
</location>
</feature>
<feature type="active site" description="Proton acceptor" evidence="18 19">
<location>
<position position="138"/>
</location>
</feature>
<feature type="binding site" description="ATP" evidence="18">
<location>
<position position="45"/>
</location>
</feature>
<feature type="site" description="Cleavage; by CASP8" evidence="23">
<location>
<begin position="324"/>
<end position="325"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by IKKA and IKKB" evidence="36">
<location>
<position position="6"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by autocatalysis" evidence="16">
<location>
<position position="20"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by IKKA and IKKB" evidence="36 52">
<location>
<position position="25"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by RIPK3 and autocatalysis" evidence="16">
<location>
<position position="161"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by autocatalysis" evidence="16 49">
<location>
<position position="166"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="36">
<location>
<position position="303"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by MAP3K7" evidence="12 13 36">
<location>
<position position="320"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by MAP3K7" evidence="14">
<location>
<position position="331"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by MAP3K7" evidence="36">
<location>
<position position="333"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="11">
<location>
<position position="384"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)" evidence="32">
<location>
<position position="377"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_037690" evidence="59">
<location>
<begin position="108"/>
<end position="153"/>
</location>
</feature>
<feature type="sequence variant" description="In a colorectal adenocarcinoma sample; somatic mutation; dbSNP:rs774996232." id="VAR_041039" evidence="33">
<original>A</original>
<variation>V</variation>
<location>
<position position="64"/>
</location>
</feature>
<feature type="sequence variant" description="In a colorectal adenocarcinoma sample; somatic mutation; dbSNP:rs758268804." id="VAR_041040" evidence="33">
<original>V</original>
<variation>I</variation>
<location>
<position position="81"/>
</location>
</feature>
<feature type="sequence variant" description="In a colorectal adenocarcinoma sample; somatic mutation; dbSNP:rs759012409." id="VAR_041041" evidence="33">
<original>A</original>
<variation>V</variation>
<location>
<position position="220"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs17548383." id="VAR_021109" evidence="58">
<original>E</original>
<variation>K</variation>
<location>
<position position="234"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs34872409." id="VAR_041042" evidence="33">
<original>A</original>
<variation>S</variation>
<location>
<position position="404"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs3173519." id="VAR_058285" evidence="30 53 54">
<original>A</original>
<variation>V</variation>
<location>
<position position="438"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs35722193." id="VAR_041043" evidence="33">
<original>A</original>
<variation>V</variation>
<location>
<position position="443"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs55861377." id="VAR_041044" evidence="33">
<original>A</original>
<variation>V</variation>
<location>
<position position="569"/>
</location>
</feature>
<feature type="mutagenesis site" description="Phophomimetic mutant. Significant loss of kinase activity." evidence="52">
<original>S</original>
<variation>D</variation>
<location>
<position position="25"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes kinase activity." evidence="52 54">
<original>K</original>
<variation>A</variation>
<location>
<position position="45"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decreases RIPK1 kinase activity." evidence="36">
<original>S</original>
<variation>A</variation>
<location>
<position position="161"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on RIPK1 autophosphorylation." evidence="36">
<original>S</original>
<variation>E</variation>
<location>
<position position="161"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes cleavage by caspase-8." evidence="23">
<original>D</original>
<variation>K</variation>
<location>
<position position="324"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes RIP-mediated NF-Kappa-B activation." evidence="32">
<original>K</original>
<variation>R</variation>
<location>
<position position="377"/>
</location>
</feature>
<feature type="mutagenesis site" description="Blocks homodimerization, necroptosis and apoptosis." evidence="49">
<original>K</original>
<variation>R</variation>
<location>
<position position="599"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 3; BAG36858." ref="3" evidence="62">
<original>R</original>
<variation>I</variation>
<location>
<position position="258"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 3; BAG36858." ref="3" evidence="62">
<original>R</original>
<variation>S</variation>
<location>
<position position="286"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 8; AAC50137." ref="8" evidence="62">
<original>T</original>
<variation>S</variation>
<location>
<position position="514"/>
</location>
</feature>
<feature type="strand" evidence="10">
<location>
<begin position="10"/>
<end position="12"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="14"/>
<end position="16"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="17"/>
<end position="19"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="20"/>
<end position="22"/>
</location>
</feature>
<feature type="helix" evidence="7">
<location>
<begin position="25"/>
<end position="28"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="30"/>
<end position="36"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="37"/>
<end position="39"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="40"/>
<end position="51"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="54"/>
<end position="56"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="57"/>
<end position="68"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="78"/>
<end position="84"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="87"/>
<end position="93"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="100"/>
<end position="104"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="106"/>
<end position="108"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="112"/>
<end position="131"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="141"/>
<end position="143"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="144"/>
<end position="146"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="152"/>
<end position="154"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="163"/>
<end position="168"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="171"/>
<end position="173"/>
</location>
</feature>
<feature type="helix" evidence="9">
<location>
<begin position="190"/>
<end position="192"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="195"/>
<end position="197"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="201"/>
<end position="203"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="207"/>
<end position="223"/>
</location>
</feature>
<feature type="helix" evidence="8">
<location>
<begin position="228"/>
<end position="230"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="234"/>
<end position="242"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="249"/>
<end position="251"/>
</location>
</feature>
<feature type="turn" evidence="7">
<location>
<begin position="252"/>
<end position="255"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="258"/>
<end position="267"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="272"/>
<end position="274"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="278"/>
<end position="292"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="294"/>
<end position="296"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="297"/>
<end position="309"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="310"/>
<end position="312"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="533"/>
<end position="542"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="575"/>
<end position="577"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="584"/>
<end position="593"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="599"/>
<end position="604"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="609"/>
<end position="618"/>
</location>
</feature>
<feature type="turn" evidence="6">
<location>
<begin position="619"/>
<end position="622"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="624"/>
<end position="643"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="646"/>
<end position="655"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="659"/>
<end position="668"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4ITH"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4ITJ"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4NEU"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5HX6"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5V7Z"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PDB" id="6AC5"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PDB" id="6C3E"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PDB" id="6C4D"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000244">
<source>
<dbReference type="PDB" id="6NW2"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000244">
<source>
<dbReference type="PDB" id="6NYH"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="15144186"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18669648"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q60855"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q9ZUF4"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000255"/>
<evidence key="17" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00064"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00159"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU10027"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10356400"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10358032"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10409763"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10521396"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11101870"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11116146"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11734559"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11854271"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14754897"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15258597"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16127453"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16603398"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17344846"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17389591"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17449468"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18408713"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18442983"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18450452"/>
</source>
</evidence>
<evidence key="39" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19524512"/>
</source>
</evidence>
<evidence key="40" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19524513"/>
</source>
</evidence>
<evidence key="41" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21455173"/>
</source>
</evidence>
<evidence key="42" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21887730"/>
</source>
</evidence>
<evidence key="43" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21931591"/>
</source>
</evidence>
<evidence key="44" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22265414"/>
</source>
</evidence>
<evidence key="45" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23473668"/>
</source>
</evidence>
<evidence key="46" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24130170"/>
</source>
</evidence>
<evidence key="47" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25736436"/>
</source>
</evidence>
<evidence key="48" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="28659487"/>
</source>
</evidence>
<evidence key="49" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="29440439"/>
</source>
</evidence>
<evidence key="50" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="29883609"/>
</source>
</evidence>
<evidence key="51" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="30026316"/>
</source>
</evidence>
<evidence key="52" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="30988283"/>
</source>
</evidence>
<evidence key="53" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7538908"/>
</source>
</evidence>
<evidence key="54" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8612133"/>
</source>
</evidence>
<evidence key="55" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9044836"/>
</source>
</evidence>
<evidence key="56" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9927690"/>
</source>
</evidence>
<evidence key="57" type="ECO:0000269">
<source ref="33"/>
</evidence>
<evidence key="58" type="ECO:0000269">
<source ref="4"/>
</evidence>
<evidence key="59" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="14702039"/>
</source>
</evidence>
<evidence key="60" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="25459879"/>
</source>
</evidence>
<evidence key="61" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="31457011"/>
</source>
</evidence>
<evidence key="62" type="ECO:0000305"/>
<sequence length="671" mass="75931" checksum="976E2428D525A9B2" modified="2005-02-01" version="3">MQPDMSLNVIKMKSSDFLESAELDSGGFGKVSLCFHRTQGLMIMKTVYKGPNCIEHNEALLEEAKMMNRLRHSRVVKLLGVIIEEGKYSLVMEYMEKGNLMHVLKAEMSTPLSVKGRIILEIIEGMCYLHGKGVIHKDLKPENILVDNDFHIKIADLGLASFKMWSKLNNEEHNELREVDGTAKKNGGTLYYMAPEHLNDVNAKPTEKSDVYSFAVVLWAIFANKEPYENAICEQQLIMCIKSGNRPDVDDITEYCPREIISLMKLCWEANPEARPTFPGIEEKFRPFYLSQLEESVEEDVKSLKKEYSNENAVVKRMQSLQLDCVAVPSSRSNSATEQPGSLHSSQGLGMGPVEESWFAPSLEHPQEENEPSLQSKLQDEANYHLYGSRMDRQTKQQPRQNVAYNREEERRRRVSHDPFAQQRPYENFQNTEGKGTAYSSAASHGNAVHQPSGLTSQPQVLYQNNGLYSSHGFGTRPLDPGTAGPRVWYRPIPSHMPSLHNIPVPETNYLGNTPTMPFSSLPPTDESIKYTIYNSTGIQIGAYNYMEIGGTSSSLLDSTNTNFKEEPAAKYQAIFDNTTSLTDKHLDPIRENLGKHWKNCARKLGFTQSQIDEIDHDYERDGLKEKVYQMLQKWVMREGIKGATVGKLAQALHQCSRIDLLSSLIYVSQN</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>